Fidelity Investments
SVNT

Fidelity Investments’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Fidelity Investments’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-348,908
Closed -$195K – 2732
2013
Q2 		$195K Buy
+348,908
New +$243K ﹤0.01% 2554

Other funds holding SVNT

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments's SVNT Position: Q3 2013 in Review

Fidelity Investments sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2013, closing a stake of 348,908 shares — an estimated $195K sold.

Fidelity Investments first reported a position in SVNT in Q2 2013 and held it in 1 quarter. The position peaked at $195K in Q2 2013. 41 funds tracked by Wall St. Rank hold SVNT as of Q3 2013.

  • Fidelity Investments reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Fidelity Investments sold 348,908 SAVIENT PHARMACEUTICALS INC shares in Q3 2013, an estimated $195K.
  • Fidelity Investments first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Fidelity Investments's SAVIENT PHARMACEUTICALS INC position peaked at $195K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2013.

Based on Fidelity Investments's 13F filing for Q3 2013, filed 14 Nov 2013.